Climb Bio, Inc. Announces $110.0 Million Private Placement
Climb Bio announced a $110 million private placement, selling 9.48 million shares of common stock at $9.50 per share and pre-funded warrants to purchase 2.1 million shares. The offering was supported by a broad syndicate of institutional investors, including RA Capital Management, Adage Capital Partners, and Cormorant Asset Management.
Key figures
- Offering Price
- 9.5
- Shares Offered
- 9481000
- Warrant price
- 9.4999
- Warrants offered
- 2106000
- Warrant exercise price
- 0.0001
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.